All posts by: Michael Zand

About Michael Zand

Lonza and Selecta Biosciences (SELB) Announce Manufacturing Agreement for Anc80-AAV-Based Gene Therapy – StreetInsider.com

Continue reading

2017-02-16 NEWS

Lonza and Selecta Biosciences (SELB) Announce Manufacturing Agreement for Anc80-AAV-Based Gene Therapy
StreetInsider.com
Under the terms of the agreement, Lonza will produce an Anc80-AAV-based gene therapy product for Selecta’s proprietary program for the treatment of Methylmalonic Acidemia (MMA), a rare inborn error of metabolism, and may in the future produce other …

and more »

Continue reading

2017-02-16 NEWS

STAT

And the CRISPR science prizes go to…
STAT
In case you haven’t heard enough about Wednesday’s CRISPR patent ruling 1, we decided to tally up the winners in another court: the world of scientific prizes. Turns out, it’s not so easy to discern who’s ahead in prizes awarded for science related to